Searched for
BIOLOGICAL E.
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- Earth observation can add USD 263 billion in annual economic value globally: ReportEarth observation data offers a massive economic opportunity, potentially worth over USD 700 billion annually. However, a significant porti...
- South Korean shares hit record high on export surge, Nvidia optimismSouth Korean stocks surged to record highs on Monday. Strong chip exports fueled the rally, boosted by hopes of AI collaborations with Nvid...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Tom Kane cause of death: Beloved voice actor behind Yoda and Powerpuff Girls’ Professor dies at 64- here's what happened to himLegendary voice actor Tom Kane, known for his iconic roles as Yoda in Star Wars: The Clone Wars and Professor Utonium in The Powerpuff Girl...
- NEET paper leak: Plea in SC seeks NTA revamp or replacement, interim monitoring panelA medical body has urged the Supreme Court to overhaul the National Testing Agency (NTA) due to recurring NEET-UG paper leaks, calling it a...
- Curb your overenthusiasm: Why India must avoid early overregulation while drafting rules for new techIndia faces a critical choice in regulating new industries like AI and genomics. Overly cautious, ex-ante regulations, similar to the histo...
- Why do tigers rest for 16–20 hours a day? IITian-IFS officer shares fascinating explanation.Tigers need long rest periods for survival. IFS officer Himanshu Tyagi explains this is due to energy conservation. Tigers understand calor...
- ET Most Innovative AI Product Awards 2026: Honouring AI Innovations reshaping Life Sciences & Pharma ResearchThe Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...
- Karnataka launches India’s first state-led spacetech CoE in BengaluruKarnataka has launched India's first state-led Centre of Excellence for Space Technology (CoE SpaceTech Foundation) in Bengaluru. This init...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- These 5 books helped Ankur Warikoo master his habits, mindset, and careerEntrepreneur Ankur Warikoo revealed five books that profoundly shaped his thinking and approach to work. These influential titles, includin...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Biological E to invest Rs 1800 crore to augment vaccine capacity, injectables, R&DAccording to a press release issued by the state government, the expansion is primarily targeted to ramp up the manufacturing of vaccines a...
- COVID-19: Government to expedite process of recognition of Biological E Corbevax by other countries"It is necessary to quickly initiate the process of recognition of the Corbevax vaccine and its certificate by other countries while Biolog...
- Biological E's Corbevax gets nod for phase 2/3 trials on those aged 5-18India's drug regulator has granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3 clinical trials of its COVID-19 ...
- Mansukh Mandaviya holds meeting with Biological-E MD on progress of Covid vaccine Corbevax"Met Ms Mahima Datla, MD of @Biological_E , who briefed me on the progress of their upcoming #COVID19 vaccine, Corbevax. I assured all the ...
- Biological E signs pact with J&J for Covid-19 vaccine technologyBiological E will produce J&J's vaccine at its vaccine production facilities and sell them both in India and export across various global m...
Load More
